Two funds investing in defensive stocks are the only exchange-traded funds in the world that had a positive return every year over the past decade, CNBC Pro research has found.
The two funds stood out among 8,300 equity ETFs worldwide screened by CNBC Pro using FactSet data.
Over that period, the ETF more than doubled investors' money, with a cumulative total price gain of 118%.
While the MSCI Healthcare index, valued in euros, dipped slightly into negative territory in 2016, 2020 and 2022, the Amundi ETF's total returns have remained positive because of the weakness in the pound sterling.
However, Tabet also pointed out that the health-care sector, especially European pharma, tends to underperform in election years.
Persons:
Joakim Tabet, Kepler, Tabet, Vincent Denoiseux, David Evans, Evans, Kepler Cheuvreux
Organizations:
CNBC, Healthcare UCITS, London Stock Exchange, TSX, Consumer Staples, CNBC Pro, Outlook Novo Nordisk, Novo Nordisk's, pharma, European pharma
Locations:
Canadian, Europe, Danish, Novo, U.S